Global Cyromazine Market: By type (solution and granule), by application (Crop Protection, Veterinary medicines, and infrastructure pest control), by regions (North America, Asia Pacific, Europe, Latin America, and Oceania).
REPORT HIGHLIGHT
The global cyromazine market was worth US$ 1.27 million in 2017 and is anticipated to grow at a CAGR of 6.03%, reaching US$ 2.18 million by 2026.
Cyromazine is the melamine derivative of cyclopropyl & amino triazine that acts as an insect growth regulator (IGR). Cyromazine is used in veterinary medicine and agriculture. By interfering with the hormonal regulation of development, cyromazine and other IGRs disrupt the life cycle of insects. IGRs obstruct the insect's natural development and growth, causing it to die before reaching adulthood. IGRs are also effective against pests that have developed resistance to the insecticide. They are non-polluting, biodegradable, and non-persistent. They are non-toxic to the beneficial microbes present in the soil.
MARKET DYNAMICS
IGRs are materials with a high level of efficiency. As a result, demand from various industries, including agriculture, residential, and commercial, has increased. In recent years, the rise in integrated pest control and organic agricultural techniques in rising nations like India and China has helped to boost demand. Improving the dairy industry and advanced veterinary healthcare practices also opens new insect growth regulators such as cyromazine.
Increasing population, rising need for food, and rising demand for agricultural goods are the main drivers projected to drive market growth over the forecast period. IGRs help achieve economies of scale since they are cost-efficient and effective in small quantities. Because of the growing popularity of organic farming, IGRs are in high demand. Crop protection agents used in organic farming decay quickly and have a low environmental impact because they are sourced primarily from natural sources. In organic farming, insect growth regulators, botanical extracts from plants, synthetic pheromone medicines, and various other biological pesticides are routinely employed. These pesticides have a negligible effect on beneficial insects and the environment. Increasing demand for organic food in developing countries is boosting demand for IGR in the sustainable agriculture sector.
Pesticide usage is increasing, resulting in negative consequences for arable land. Synthetic pesticides pollute soil and groundwater, harming both beneficial microorganisms and plants. Pesticides have developed resistance due to repeated use, so they do not affect the pests' life cycle. The increasing adoption of sustainable agriculture practices is increasing the demand for insect growth regulators such as cyromazine. Apart from this, infrastructure development is also increasing the demand for pest control products.
The slow-acting nature of cyromazine and the availability of cyromazine alternatives such as Methoprene are likely to limit market expansion. Cost-effective other IGR options against cyromazine are hampering the growth. Furthermore, one of the key problems restricting market growth is developing resistance to insect growth regulators.
MARKET SEGMENTATION
In general, the global insect growth regulator industry can be bifurcated by types such as solution and granule and by application sectors such as agricultural crop protection, veterinary medicines, infrastructure pest control, etc.
DELIVERY TYPE TAKEAWAY
The solution segment is holding a significant share by application mechanism type. Solution products are primarily used in the agriculture and infrastructure sector. Increasing application in agriculture practices is driving the solution segment. Granule type is relatively small, but it is finding new applications in new industries. The veterinary drug is mainly applied in granular form. It accounts for a significant share of fine-type delivery mechanisms.
APPLICATION TAKEAWAY
Crop protection had the highest revenue share of the worldwide cyromazine market in 2017, accounting for 78.4 percent of total revenue. Insect growth regulators, such as cyromazine, are in great demand in the agricultural sector to protect crops from insects and enhance crop yields. According to the Food and Agriculture Organization (FAO) data, Brazil used about 60.6 thousand tonnes of insecticides in 2016. Increasing infrastructure development in developed and emerging economies boosts the pest control market in the construction segment. Veterinary medicine is a relatively small segment. But due to the increasing need of the dairy industry is increasing demand for animal health services. The growing trend of pet adoption is also opening new application opportunities for veterinary medicines.
REGIONAL TAKEAWAYS
Global industry can be analyzed by North America, Europe, Asia Pacific, the Middle East and South Africa, and Latin America. North America, among geographies, maintained a prominent market position in the worldwide cyromazine market in 2017, owing to rising family income in the area, which boosts purchasing power and, therefore, food consumption. Due to the increasing agricultural business in nations such as India, Asia Pacific is the fastest-growing region, accounting for 37.2 percent of the total market share in 2017. Foodgrain output in India during the crop year 2017-2018 was 279.51 million tonnes, according to an India Brand Equity Foundation study on Agriculture and Allied Industries released in May 2018. Agriculture exports accounted for $3.15 billion in April 2018. As a result, increased agricultural industry expansion is projected to boost crop protection solutions, which will drive demand for cyromazine pesticides. Expanding the dairy industry and animal husbandry in developing countries like India increases the need for veterinary medicines. Asia Pacific region is also expected to register high growth during the forecast period among all other territories.
COVID-19 IMPACT
Due to interrupted supply chains and lukewarm demand for a long time, the COVID-19 pandemic impacted nearly every sector of the global economy. During the epidemic, agriculture was one of the rare exceptions. Food consumption was substantially unaffected during this period due to its priority sector position and healthy rural eco-system. People began to embrace a better lifestyle during the period, and demand for various food products increased drastically. Governments across the regions implemented business-friendly policies for companies in the agriculture and food industry. Because of the priority status of the agricultural commodity market, market access for farm products was relatively unscathed. The infrastructure sector went through a rough patch during the pandemic period. It impacted the pest control application market. The veterinary medicine market was also unaffected. Due to this type of mix output from application markets, the cyromazine industry is expected to grow steadily even during pandemics.
KEY PLAYERS
Prominent companies in the global market are Arysta Lifesciences, Topsen Biotech Co. Ltd., Bayer AG, Jurox Pvt. Ltd., Orion Agriscience, ADAMA Agricultural Solutions, Shandong Luxi Animal Medicine, Shanghai Kangbaolai Pharma, Zhejiang Guobang Pharmaceutical, Syngenta AG, Brilliant Pharmaceutical group, Lasa Supergenerics, Toronto Research Chemicals Inc and Elanco Animal Health Inc
To enhance their market share, companies are turning to inorganic development techniques like mergers and acquisitions. For example, Bayer completed the acquisition of Monsanto in June 2018, which will aid Bayer in strengthening its agriculture business by delivering more productive and sustainable agricultural solutions.
To meet the rising demand for cyromazine, players in the global cyromazine market are employing various growth tactics. For example, in December 2017, ADAMA and ALRISE Biosystems formed a research and development partnership to develop highly effective and long-lasting crop protection solutions for farmers with lower active component doses.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2016 to 2018
- Base Year – 2019
- Estimated Year – 2020
- Projected Year – 2021 to 2027
TARGET AUDIENCE
- Manufacturers
- Raw Material Suppliers
- Distributors
- Original Equipment Manufacturers
- Consulting Firms
- Government and Regional Agencies
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CYROMAZINE MARKET KEY PLAYERS
- Arysta Lifesciences
- Topsen Biotech Co. Ltd.
- Bayer AG
- Elanco Animal Health Inc.
- Jurox Pvt. Ltd.
- Lasa Supergenerics
- Orion Agriscience
- Syngenta AG
- ADAMA Agricultural Solutions
- Toronto Research Chemicals Inc.
- Shandong Luxi Animal Medicine
- Brilliant Pharmaceutical group
- Shanghai Kangbaolai Pharma
- Zhejiang Guobang Pharmaceutical
GLOBAL CYROMAZINE MARKET, BY DELIVERY TYPE
- Solution
- Granule
GLOBAL CYROMAZINE MARKET, BY APPLICATION
- Crop Protection
- Veterinary medicines
- Infrastructure pest control
GLOBAL CYROMAZINE MARKET, BY REGIONS
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Rest of MEA
TABLE OF CONTENT
1. CYROMAZINE MARKET OVERVIEW
1.1. Study Scope
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Types
2.1.2. Market Snippet by Applications
2.1.3. Market Snippet by Region
2.2. Competitive Insights
3. CYROMAZINE KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. CYROMAZINE APPLICATION STUDY
4.1. Porter’s Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. CYROMAZINE MARKET: COVID-19 IMPACT ANALYSIS
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. CYROMAZINE MARKET LANDSCAPE
6.1. Market Share Analysis, 2019
6.2. Key Innovators Analysis
6.3. Breakdown Data, by Key Manufacturer
6.3.1. Established Players’ Analysis
6.3.2. Emerging Players’ Analysis
7. CYROMAZINE MARKET – BY TYPES
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2020 & 2027 (%)
7.2. Solution type
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
7.3. Granule type
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
8. CYROMAZINE MARKET– BY APPLICATIONS
8.1. Overview
8.1.1. Segment Share Analysis, By Applications, 2020 & 2027 (%)
8.2. Crop protection
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
8.3. Veterinary medicines
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
8.4. Infrastructure pest control
8.4.1. Overview
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9. CYROMAZINE MARKET– BY GEOGRAPHY
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
9.2. North America
9.2.1. Overview
9.2.2. Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Billion)
9.2.4. North America Market Size and Forecast, By Types, 2016 - 2027 (US$ Billion)
9.2.5. North America Market Size and Forecast, By Applications, 2016 - 2027 (US Billion)
9.2.6. U.S.
9.2.6.1. Overview
9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.2.6.3. U.S. Market Size and Forecast, By TYPES, 2016 - 2027 (US$ Billion)
9.2.6.4. U.S. Market Size and Forecast, By Applications, 2016 - 2027 (US Billion)
9.2.7. Canada
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.2.7.3. Canada Market Size and Forecast, By Types, 2016 - 2027 (US$ Billion)
9.2.7.4. Canada Market Size and Forecast, By Applications, 2016 - 2027 (US Billion)
9.3. Europe
9.3.1. Overview
9.3.2. Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Billion)
9.3.4. Europe Market Size and Forecast, By Types, 2016 - 2027 (US$ Billion)
9.3.5. Europe Market Size and Forecast, By Applications, 2016 - 2027 (US Billion)
9.3.6. Germany
9.3.6.1. Overview
9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.3.6.3. Germany Market Size and Forecast, By Types, 2016 - 2027 (US$ Billion)
9.3.6.4. Germany Market Size and Forecast, By Applications, 2016 - 2027 (US Billion)
9.3.7. Italy
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.3.7.3. Italy Market Size and Forecast, By Types, 2016 - 2027 (US$ Billion)
9.3.7.4. Italy Market Size and Forecast, By Applications, 2016 - 2027 (US Billion)
9.3.8. United Kingdom
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.3.8.3. U.K. Market Size and Forecast, By Types, 2016 - 2027 (US$ Billion)
9.3.8.4. U.K. Market Size and Forecast, By Applications, 2016 - 2027 (US Billion)
9.3.9. France
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.3.9.3. France Market Size and Forecast, By Types, 2016 - 2027 (US$ Billion)
9.3.9.4. France Market Size and Forecast, By Applications, 2016 - 2027 (US Billion)
9.3.10. Rest of Europe
9.3.10.1. Overview
9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.3.10.3. Rest of Europe Market Size and Forecast, By Types, 2016 - 2027 (US$ Billion)
9.3.10.4. Rest of Europe Size and Forecast, By Applications, 2016 - 2027 (US Billion)
9.4. Asia Pacific
9.4.1. Overview
9.4.2. Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Billion)
9.4.4. Asia Pacific Market Size and Forecast, By Types, 2016 - 2027 (US$ Billion)
9.4.5. Asia Pacific Market Size and Forecast, By Applications, 2016 - 2027 (US Billion)
9.4.6. India
9.4.6.1. Overview
9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.4.6.3. India Market Size and Forecast, By Types, 2016 - 2027 (US$ Billion)
9.4.6.4. India Market Size and Forecast, By Applications, 2016 - 2027 (US Billion)
9.4.7. China
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.4.7.3. China Market Size and Forecast, By Types, 2016 - 2027 (US$ Billion)
9.4.7.4. China Market Size and Forecast, By Applications, 2016 - 2027 (US Billion)
9.4.8. Japan
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.4.8.3. Japan Market Size and Forecast, By Types, 2016 - 2027 (US$ Billion)
9.4.8.4. Japan Market Size and Forecast, By Applications, 2016 - 2027 (US billion)
9.4.9. Rest of APAC
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.4.9.3. Rest of APAC Market Size and Forecast, By Types, 2016 - 2027 (US$ Billion)
9.4.9.4. Rest of APAC Market Size and Forecast, By Applications, 2016 - 2027 (US Billion)
9.5. Latin America
9.5.1. Overview
9.5.2. Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Billion)
9.5.4. Latin America Market Size and Forecast, By TYPES, 2016 - 2027 (US$ Billion)
9.5.5. Latin America Market Size and Forecast, By Applications, 2016 - 2027 (US Billion)
9.5.6. Brazil
9.5.6.1. Overview
9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.5.6.3. Brazil Market Size and Forecast, By Types, 2016 - 2027 (US$ Billion)
9.5.6.4. Brazil Market Size and Forecast, By Applications, 2016 - 2027 (US Billion)
9.5.7. Mexico
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.5.7.3. Mexico Market Size and Forecast, By Types, 2016 - 2027 (US$ Billion)
9.5.7.4. Mexico Market Size and Forecast, By Applications, 2016 - 2027 (US Billion)
9.5.8. Argentina
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.5.8.3. Argentina Market Size and Forecast, By Types, 2016 - 2027 (US$ Billion)
9.5.8.4. Argentina Market Size and Forecast, By Applications, 2016 - 2027 (US Billion)
9.5.9. Rest of LATAM
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.5.9.3. Rest of LATAM Market Size and Forecast, By Types, 2016 - 2027 (US$ Billion)
9.5.9.4. Rest of LATAM Market Size and Forecast, By Applications, 2016 - 2027 (US Billion)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Billion)
9.6.4. Middle East and Africa Market Size and Forecast, By Types, 2016 - 2027 (US$ Billion)
9.6.5. Middle East and Africa Market Size and Forecast, By Applications, 2016 - 2027 (US$ Billion)
9.6.6. Saudi Arabia
9.6.6.1. Overview
9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.6.6.3. Saudi Arabia Market Size and Forecast, By Types, 2016 - 2027 (US$ Billion)
9.6.6.4. Saudi Arabia Market Size and Forecast, By Applications, 2016 - 2027 (US Billion)
9.6.7. United Arab Emirates
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.6.7.3. U.A.E. Market Size and Forecast, By Types, 2016 - 2027 (US$ Billion)
9.6.7.4. U.A.E. Market Size and Forecast, By Applications, 2016 - 2027 (US Billion)
9.6.8. Rest of MEA
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.6.8.3. Rest of MEA Market Size and Forecast, By Types, 2016 - 2027 (US$ Billion)
9.6.8.4. Rest of MEA Market Size and Forecast, By Applications, 2016 - 2027 (US Billion)
10. KEY VENDOR ANALYSIS
10.1. Competitive Dashboard
10.2. Company Profiles
10.2.1. Arysta Lifesciences
10.2.1.1. Company Overview
10.2.1.2. Financial Performance
10.2.1.3. Product Benchmarking
10.2.1.4. Strategic Initiatives
10.2.2. Topsen Biotech Co. Ltd.
10.2.3. Bayer AG
10.2.4. Elanco Animal Health Inc.
10.2.5. Jurox Pvt. Ltd.
10.2.6. Lasa Supergenerics
10.2.7. Orion Agriscience
10.2.8. Syngenta AG
10.2.9. ADAMA Agricultural Solutions
10.2.10. Toronto Research Chemicals Inc.
10.2.11. Shandong Luxi Animal Medicine
10.2.12. Brilliant Pharmaceutical group
10.2.13. Shanghai Kangbaolai Pharma
10.2.14. Zhejiang Guobang Pharmaceutical
11. 360 DEGREE ANALYST VIEW
12. APPENDIX
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
